Company Mereo BioPharma Group PLC London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rare Disease Therapies
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 53 | 15-02-28 | |
John P. Richard
FOU | Founder | 66 | 15-02-28 |
Founder | 64 | 15-07-09 | |
Charles Sermon
FOU | Founder | 55 | 15-02-28 |
Christine Fox
DFI | Director of Finance/CFO | 43 | 21-01-30 |
Michael Wyzga
CHM | Chairman | 69 | 19-04-22 |
Suba Krishnan
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-12-06 |
John Lewicki
CTO | Chief Tech/Sci/R&D Officer | 72 | 20-06-30 |
Richard Francis
PRN | Corporate Officer/Principal | - | 19-07-31 |
Corporate Officer/Principal | 53 | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 19-04-22 |
Director/Board Member | - | 22-11-09 | |
Director/Board Member | 59 | 19-04-22 | |
Founder | 64 | 15-07-09 | |
Director/Board Member | 70 | 15-06-30 | |
Pierre Jacquet
BRD | Director/Board Member | 57 | 21-09-19 |
Justin Roberts
BRD | Director/Board Member | - | 22-11-09 |
Annalisa Jenkins
BRD | Director/Board Member | 58 | 22-11-09 |
Jeremy Bender
BRD | Director/Board Member | 52 | 20-09-30 |
Daniel Shames
BRD | Director/Board Member | - | 22-11-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 643,204,794 | 301,926,833 ( 46.94 %) | 0 | 46.94 % |
Company contact information
Mereo BioPharma Group Plc
1 Cavendish Place 4th Floor
W1G 0QF, London
+44 33 3023 7300
http://www.mereobiopharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.41% | 21.31B | |
-16.61% | 21.21B | |
-4.92% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |